PrimeRFP SCOUT · Federal Contract Recompete Brief

75N93023C00019AMR BAA research area 001 — Icahn School of Medicine at Mount Sinai

Icahn School of Medicine at Mount Sinai holds $259.7M across 47 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards in the incumbent pipeline. Competition previously drew 19 offers. Set-aside status: Unrestricted. Recompete timing centers on the May 31, 2028 PoP end — agencies typically plan 12–18 months ahead.

National Institutes Of Health Nci
Awarding office
Icahn School of Medicine at Mount Sinai
Recipient
May 31, 2028
PoP end
$15.9M
Obligated
$22.7M
Potential
541715
NAICS
AN12
PSC
Unrestricted
Set-aside
19 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number75N93023C00019
AgencyNational Institutes Of Health Nci
Awarding officeNational Institutes Of Health Nci
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentIcahn School of Medicine at Mount Sinai
CAGE1QSQ9
UEIC8H9CNG1VBD9
NAICS541715
PSCAN12
Place of performanceNEW YORK NY
Pricing typeCost No Fee
Extent competedFull And Open Competition
Related solicitationBAA2022-1
PoP startJun 1, 2023
PoP end (current)May 31, 2028
Obligated$15.9M
Current value$15.9M
Potential value$22.7M

BAA Research Area 001: Development of Vaccine Candidates for Biodefense, Antimicrobial Resistant (AMR) Infections and E… is a federal Unrestricted award for National Institutes Of Health Nci held by Icahn School of Medicine at Mount Sinai. Estimated value $22.7M ($15.9M obligated). Current period of performance ends May 31, 2028. Last award drew 19 bidders. Place of performance: NEW YORK NY. Related solicitation BAA2022-1.

Baa research area 001: development of vaccine candidates for biodefense, antimicrobial resistant (amr) infections and emerging infectious diseases. Latest action is a modification.

Recompete timing

Public
● Expiring in 586 days

Current PoP ends May 31, 2028 (586 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Dec 1, 2026.

Want the durability read on 75N93023C00019? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Icahn School of Medicine at Mount Sinai — $259.7M obligated across 47 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($259.7M) · all agencies
Department of Health and Human Services (HHS)$250.9M · 97%National Aeronautics and Space Administration (NASA)$4.0M · 2%Department of Veterans Affairs (VA)$2.9M · 1%Department of Defense (DOD)$1.9M · 1%
Open full company profile →

Related awards

Same incumbent
36C24226N0420
TRANSPLANT SURGEONS
$467K
Mar 31, 2027
36C24226N0443
LIVING DONOR EVALUATIONS AND SURGERY FOR THE VA
$166K
Mar 31, 2027
75N93019C00051
EO14042-THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNO…
$111.2M
Jul 9, 2027
75D30122C15187
DATA CENTER 2 - ISMMS
$28.2M
Sep 28, 2027
80ARC022CA004
IDENTIFICATION OF BIOMARKERS AND PATHOLOGICAL MECHANISMS VIA LONGITUDINAL ANALYSIS OF NEUR…
$8.2M
Sep 29, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75N93023C00019?

75N93023C00019 (AMR BAA research area 001) is a National Institutes Of Health Nci award with a potential value of $22.7M, currently held by Icahn School of Medicine at Mount Sinai. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N93023C00019?

National Institutes Of Health Nci awarded 75N93023C00019 to Icahn School of Medicine at Mount Sinai (potential $22.7M).

Who is the incumbent on 75N93023C00019?

Icahn School of Medicine at Mount Sinai is the incumbent with $259.7M across 47 related awards in SCOUT’s public footprint. The current period of performance ends May 31, 2028.

When does Icahn School of Medicine at Mount Sinai’s 75N93023C00019 come up for recompete?

SCOUT tracks a period-of-performance end of May 31, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75N93023C00019? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N93023C00019